"
Prognostic Significance of Hematologic Markers in Patients with Head and Neck Squamous Cell Carcinomas"
written by Ryohei Oya, Yukinori Takenaka, Kengo Aoki, Hiroko Hamaguchi, Kazuya Takemura, Masayuki Nozawa, Takahiro Kitamura, Yoshifumi Yamamoto, Atsuhiko Uno,
published by
International Journal of Otolaryngology and Head & Neck Surgery,
Vol.7 No.2, 2018
has been cited by the following article(s):
|
[1]
|
Neutrophil‐to‐lymphocyte ratio as a prognostic marker for head and neck squamous cell carcinoma treated with immune checkpoint inhibitors: Meta‐analysis
Head & Neck,
2022
DOI:10.1002/hed.26997
|
|
|
|
|
[2]
|
Prognostic Utility of Platelet–Lymphocyte Ratio, Neutrophil–Lymphocyte Ratio and Monocyte–Lymphocyte Ratio in Head and Neck Cancers: A Detailed PRISMA Compliant Systematic Review and Meta-Analysis
Cancers,
2021
DOI:10.3390/cancers13164166
|
|
|
|